DEVELOPMENT OF METHODS OF SIMULATION OF THE INTERACTION OF BIOLOGICALLY ACTIVE SUBSTANCES WITH THE ACTIVE CENTER OF ANGIOTENSIN-CONVERTING ENZYME
Nowadays cardiovascular diseases are the main cause of death among the population around the word. The development of new drugs, giving a possibility to normalize blood pressure, is a promising direction in the field of pharmacy and medicine. Now inhibitors of angiotensinconverting enzyme (ACE) are...
Main Authors: | A. A. Glushko, A. S. Chiriapkin, V. S. Chiriapkin, A. M. Murtuzalieva, Yu. A. Polkovnikova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Pyatigorsk Medical and Pharmaceutical Institute - branch of Volgograd State Medical University
2017-10-01
|
Series: | Farmaciâ i Farmakologiâ (Pâtigorsk) |
Subjects: | |
Online Access: | https://www.pharmpharm.ru/jour/article/view/271 |
Similar Items
-
The effects of angiotensin-converting enzyme inhibitors in heart recipients: a single center experience
by: А. О. Shevchenko, et al.
Published: (2019-01-01) -
POTENTIAL OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS IN THE TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND CORONARY HEART DISEASE
by: A. G. Evdokimova, et al.
Published: (2013-02-01) -
Angiotensin Converting Enzyme Inhibitor-related Angioedema: A Case of an Unexpected Death
by: Eray Atalay, et al.
Published: (2015-11-01) -
SOME ASPECTS OF THE LISINOPRIL USAGE IN ARTERIAL HYPERTENSION TREATMENT
by: N. A. Jaiani
Published: (2016-01-01) -
Can angiotensin-converting enzyme inhibitors impact cognitive decline in early stages of Alzheimer's disease? An overview of research evidence in the elderly patient population
by: K Rygiel
Published: (2016-01-01)